Dr Paolo Lin

Paulo Lin, Director of Formulation Development at Acuitas Therapeutics, has nearly 20 years’ experience in the lipid nanoparticle field. He has contributed to more than 60 peer-reviewed publications, including in high-impact journals such as Cell and Nature, and is listed as an inventor on 17 patent families with 110 active applications and 26 granted patents worldwide. Paulo earned his BSc (Hons) and PhD in Biochemistry and Molecular Biology from the University of British Columbia. At Acuitas, he and his team have supported hundreds of programmes, contributing to more than 30 licensed products, including major advances in direct LNP preparation and the optimisation of manufacturing processes.